Titan Gel Serum Protein Control: SPE Control Cat. No 5136 1 x 2.0 mL
FDA Device Recall #Z-2434-2019 — Class II — October 14, 2016
Recall Summary
| Recall Number | Z-2434-2019 |
| Classification | Class II — Moderate risk |
| Date Initiated | October 14, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Helena Laboratories, Inc. |
| Location | Beaumont, TX |
| Product Type | Devices |
| Quantity | 65 kits |
Product Description
Titan Gel Serum Protein Control: SPE Control Cat. No 5136 1 x 2.0 mL
Reason for Recall
Due to customer-experienced complaints on narrow assay range compared to prior lots and the user being out of assay range.
Distribution Pattern
Domestic: FL, IL, MN, MT, NY, OH, TN, TX, VA, and WI OUS: Australia, Canada, Jordan, and South Korea
Lot / Code Information
Lot Codes: 1-16-5136 (Scheme: 1(st lot)-(of 20)16-(for C/N )5136) LOT 1-16-5136 EXP 3-17 Model/Catalog Number: 5136 UDI: Primary DI - M52551360
Other Recalls from Helena Laboratories, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0106-2019 | Class II | "Free and Total Protein S ELISA Kit" Cat. No. 5... | Apr 4, 2017 |
| Z-0561-2019 | Class II | Cascade Abrazo c-ACT-LR Test Card IVD FOR IN V... | Feb 24, 2017 |
| Z-0529-2019 | Class III | Gel Alkaline Phosphatase Isoenzyme Control Kit:... | Nov 7, 2016 |
| Z-0594-2019 | Class II | Cascade Abrazo c-ACT-LR Test Card IVD FOR IN V... | Apr 20, 2016 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.